Skeletal dysplasias

Archives of Disease in Childhood

Volumn 79, Issue 3, 1998, Pages 285-289

  Brook, C G D ^a   De Vries, B B A ^b  

^a MIDDLESEX HOSPITAL   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BONE DYSPLASIA; CASE REPORT; CHILD; CLINICAL EXAMINATION; GROWTH RETARDATION; HUMAN; MALE; MEDICAL PRACTICE; MOLECULAR GENETICS; PRIORITY JOURNAL; SHORT STATURE; SKELETON;

EID: 0031664388     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/adc.79.3.285     Document Type: Article

References (21)

1. International Working Group on Constitutional Diseases of Bone. International classification of osteochondrodysplasias. Am J Med Genet 1992;44:223-9.
2. Oberklaid F, Danks DM, Jensen F, Stace L, Rosshandler S. Achondroplasia and hypochondroplasia. Comments on frequency, mutation rate, and radiological features in skull and spine. J Med Genet 1979;16:140-6.
3. Shiang R, Thompson LM, Zhu Y-Z, et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell 1994;78:335-42.
4. Bellus GA, Hefferon TW, Ortiz de Luna RI, et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet 1995;56:368-73.
5. Tarvormina PL, Shiang R, Thompson LM, et al. Thanatophoric dysplasia (types I and II) caused by distinct mutations in fibroblast growth factor receptor 3. Nat Genet 1995;9:321-8.
6. Rousseau F, Saugier P, Le Merrer M, et al. Stop codon FGFR-3 mutations in thanatophoric dwarfism type I. Nat Genet 1995;10:11-12.
7. Naski MC, Wang Q, Xu J, Ornitz DM. Graded activation of fibroblast growth factor receptor 3 by mutations causing achondroplasia and thanatophoric dysplasia. Nat Genet 1996;13:233-7.
8. Bellus GA, McIntosh I, Smith EA, et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet 1995;10:357-9.
9. Lee B, Vissing H, Ramirez F, Rogers D, Rimoin D. Identification of the molecular defect in a family with spondyloepiphyseal dysplasia. Science 1989;244:978-80.
10. Tiller GE, Rimoin DL, Murray LW, Cohn DH. Tandem duplication within a type II collagen gene (COL2A1) exon in an individual with spondyloepiphyseal dysplasia. Proc Natl Acad Sci USA 1990;87:3889-93.
11. Winterpacht A, Hilbert M, Schwarze U, Mundlos S, Spranger J, Zabel BU. Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) detect. Nat Genet 1993;3:323-6.
12. Ahmad NN, Ala-Kokko L, Knowlton RG, et al. Stop codon in the procollagen II gene (COL2A1 ) in a family with the Stickler syndrome (arthro-ophthalmopathy). Proc Natl Acad Sci USA 1991;88:6624-7.
13. Vikkula M, Mariman ECM, Lui VCH, et al. Autosomal dominant and recessive osteochondroplasias associated with the COL11A2 locus. Cell 1995;80:431-7.
14. Warman ML, Abbott M, Apte SS, et al. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet 1993;5:79-82.
15. Muragaki Y, Mariman ECM, van Beersum SEC, et al. A mutation in the gene encoding the alpha2 chain of the fibril-associated collagen IX, COL9A2, causes multiple epiphyseal dysplasia (EDM2). Nat Genet 1996;12:103-5.
16. Briggs MD, Hoffman SMG, King LM, et al. Pseudoachondroplasia and multiple epiphyseal dysplasia due to mutations in the cartilage oligomeric matrix protein gene. Nat Genet 1995;10:330-6.
17. Hästbacka J, Superti-Furga A, Wilcox WR, Rimoin DL, Cohn DH, Lander ES. Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulphate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias. Am J Hum Genet 1996;58:255-62.
18. Appan S, Laurent S, Chapman M, Hindmarsh PC, Brook CGD. Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr Scand 1990;79:796-803
19. Donaldson MDC. Jury still out on growth hormone for normal short stature and Turner's syndrome. Lancet 1996;348:3-4.
20. Hindmarsh PC, Bridges NA, Brook CGD. Wider indications for treatment with biosynthetic human growth hormone in children. Clin Endocrinol 1991;34:417-28.
21. Horton WA, Rotter JI, Rimvion DL, Scott CJ, Hall JG. Standard growth curves for achondroplasia. J Paediatr 1978;93:435-8.